Clinical Trial Update: A Study of CLR325 in Chronic Stable Heart Failure Patients. [Phase 2]

View source ↗

Summary

Phase 2 trial update for CLR325 in chronic stable heart failure has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• CLR325

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Chronic Stable Heart Failure | Phase 2 | Status: COMPLETED | Results posted: 2020-03-04